Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Abeona Therapeutics (ABEO) Enterprise Value (2016 - 2025)

Abeona Therapeutics has reported Enterprise Value over the past 15 years, most recently at -$191.4 million for Q4 2025.

  • Quarterly results put Enterprise Value at -$191.4 million for Q4 2025, down 95.19% from a year ago — trailing twelve months through Dec 2025 was -$191.4 million (down 95.19% YoY), and the annual figure for FY2025 was -$191.4 million, down 95.19%.
  • Enterprise Value for Q4 2025 was -$191.4 million at Abeona Therapeutics, up from -$207.1 million in the prior quarter.
  • Over the last five years, Enterprise Value for ABEO hit a ceiling of -$18.2 million in Q3 2022 and a floor of -$225.9 million in Q2 2025.
  • Median Enterprise Value over the past 5 years was -$65.3 million (2021), compared with a mean of -$84.9 million.
  • Biggest five-year swings in Enterprise Value: skyrocketed 73.27% in 2022 and later tumbled 230.66% in 2024.
  • Abeona Therapeutics' Enterprise Value stood at -$50.9 million in 2021, then dropped by 3.09% to -$52.5 million in 2022, then dropped by 0.15% to -$52.6 million in 2023, then plummeted by 86.55% to -$98.1 million in 2024, then tumbled by 95.19% to -$191.4 million in 2025.
  • The last three reported values for Enterprise Value were -$191.4 million (Q4 2025), -$207.1 million (Q3 2025), and -$225.9 million (Q2 2025) per Business Quant data.